Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine versus olanzapine for hyperactive delirium in critically ill ICU patients
ACTRN12622001532796Phase 2Not yet recruiting
- Sponsor
- Royal Melbourne Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in delirium comparing Enteral quetiapine with Enteral olanzapine (2 arms). Primary endpoint: Alive delirium/coma free days. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
quetiapineolanzapine
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12622001532796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001532796.